Skip to main content
. 2020 Oct 7;51(4):966–970. doi: 10.1007/s11239-020-02301-6

Fig. 2.

Fig. 2

Study design and systemic heparin use while on continuous renal replacement therapy. Among total patients at risk, the percent displayed under Filter Loss 1, 2, and 3 represents the number who lost a filter divided by the total number who entered that period at risk